Dren Bio
Dren Bio is a privately held, biopharmaceutical company focused on developing therapeutic antibodies for the treatment of cancer, autoimmune and other serious diseases.
$350M ·
Led by Juvia Group · Source: Yahoo Finance
Total raised: $415M across 2 sourced rounds
All 3 rounds ↓Signals
Website registeredMay 14, 2019 (7 years old)
TIMELINE · MONEY RAISED
Dren Bio | 521 days from website to first raise on record
Raised $415M in 2 sourced rounds·1 signal before the first raise
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Round · $350M
JJuvia Group (lead),
LLightspeed (lead),
CCormorant Asset Management,
GGeneral Catalyst,
HHBM Healthcare Investments,
MMirae Asset Capital Life Science,
MMission BioCapital,
OOrbiMed,
SSR One,
TTaiho Ventures
Source: Yahoo Finance - Series B+ · $65M
AArrowMark Partners,
BBiotechnology Value Fund,
HHBM Partners, JJacket River,
PPfizer Venture Investments,
RRevelation Partners,
Source: zpr.io - Series A · amount undisclosed
88VC,
AAlexandria Venture Investments,
Source: zpr.io - Website created
Founders and team
NT
Nenad Tomasevic CEO and FounderAM
Amit Mehta COO
Investors
- HHBM Partners
Companies like Dren Bio
FFoRx Therapeutics$50M Series A · Dec 2025
MMerida Biosciences$120M Series A · May 2025
DDomain Therapeutics$41M Series A · May 2022
AAltruBio$225M Series B+ · May 2024
AAdcytherixSeries A · Oct 2025
AAnaveon$120M Series B+ · Dec 2021
Other companies backed by Juvia Group
SSoufflé Therapeutics$135M Series B+ · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/dren-bio (get a free API key).